Posted on the other board OWC Pharmaceutical Research

New Post Public Reply Private Reply Replies (2) Message Board
ison929
729
Posted on the other board

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Develops Next Generation Cannabis based Orally Disintegrating Tablet

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has completed the development of orally disintegrating next generation cannabis-based Tablet. It is a substitute for the treatment using a smoking form of medical cannabis treatment.

The next generation tablet is developed using specific amounts of cannabidiol and cannabinoids tetrahydrocannabinol and cannabis extract. The various combinations of CBD and THC are used in this tablet to address different indications. The preclinical development of this drug is already completed. It is a fast acting and can be administered in controlled dosages.

The Chief Executive Officer of OWC Pharmaceutical Research Corp, Mordechai Bignitz said the development efforts of the company improves the quality lives of patients. The next generation cannabis-based drug is one of its efforts to improve the lives of patients.

OWC Pharmaceutical Research Corp Completes the Safety Study of Cannabis based Ointment

OWC Pharmaceutical Research Corp has completed the first part of the safety study of cannabis based ointment.

The ointment consists of medical grade cannabis for different disorders. The tolerability and safety of the ointment have been studied in medical volunteers. Director (Department of Dermatology), Professor Aviv Barzilai headed the safety study of the ointment. The medical volunteers have not suffered any adverse conditions during the study of the topical ointment.

The company will initiate the phase ii clinical study after completing the second part of the safety study. The ointment is developed for the treatment of psoriasis. It is also indicated for other skin diseases as well.

Mordechai Bignitz said the company is pleased to complete the clinical testing of this ointment. He further said the company is committed to develop and validate the cannabis based products to treat life threatening diseases and debilitating conditions.

The main aim of the company is to provide access to the cost effective and safe cannabis based products to the patients suffering from diseases like psoriasis.

Brief Information about OWC Pharmaceutical Research Corp

OWC Pharmaceutical Research Corp is engaged in medical R&D through One World Cannabis Ltd, its wholly owned subsidiary based in Israel. The company develops products using cannabis for the treatment of fibromyalgia, psoriasis, multiple myeloma, migraines, and PTSD.


OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 14

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
National Showrooms Expands into Virginia with Key Buy

Updated Category News Views 6

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

Continue Reading
New Chapter Recovery Garners Key Accreditations

Updated Category News Views 9

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Continue Reading
LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 9

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
AppLovin Faces Securities Fraud Lawsuit Amid AI Claims

Updated Category News Views 6

Digging Into AppLovin's Legal Turmoil Well, it's another wrinkle in the markets' many lines. This time, we’ve got AppLovin Corporation facing the music with a securities fraud lawsuit. If you’ve got shares in NASDAQ:APP, you might want to perk up. Let the trial by fire begin, I say. The Lawsuit Details & Class Period Here we are, October 19, 2026, and the legal eagles...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 23

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 8

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 6

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
New JPA Aims to Energize Inland Empire's Water Supply

Updated Category News Views 24

Fresh Steps in San Bernardino's Infrastructure Strategy Here's a twist for you: public agencies in San Bernardino County decided enough with the same old, same old and cooked up a new joint powers authority (JPA). They call it the San Bernardino Water and Power Authority, which sounds snappy enough for a meeting room nameplate, I reckon. Who's Steering the Ship? Leading...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 10

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Shipbroking: How AI is Navigating Change and Growth

Updated Category News Views 573

Understanding the Shipbroking Market's Growth The shipbroking market is set to expand significantly, with projections indicating a growth of USD 263.7 million from 2024 to 2028. This growth is largely fueled by advances in technology and the adoption of innovation, highlighting a trend characterized by enhanced efficiency and value creation within shipping processes....

Continue Reading
Kelun-Biotech Reports Impressive Revenue Growth for 2025

Updated Category News Views 242

Kelun-Biotech's Interim Results Highlight Growth Sichuan Kelun-Biotech Pharmaceutical Co., Ltd. recently shared its compelling interim results, showcasing impressive financial performance and significant advancements in its drug pipeline for the first half of 2025. Financial Performance Overview In this reporting period, revenue reached approximately RMB950.4 million,...

Continue Reading
Ingram Micro's Road to a Successful U.S. IPO Under Platinum Equity

Updated Category News Views 341

Ingram Micro made waves back in 2023 with its U.S. IPO filing, shaking off the dust from being bought by Platinum Equity for a whopping $7.2 billion in 2021. This wasn’t just a casual stroll down memory lane; it was a strategic pivot as they geared up to re-enter the stock market after over two years in the private equity shadows. What Drove Ingram Micro's IPO Move?...

Continue Reading
Rapid Spread of Hughes Fire Challenges Firefighters in California

Updated Category News Views 226

Brush Fire Emerges in Northern Los Angeles County A brush fire has ignited and expanded rapidly in the Castaic region of northern Los Angeles County. Dubbed the Hughes Fire, it has covered a staggering area exceeding 3,400 acres, according to recent reports from various sources. Initial Response and Fire Development The fire broke out around 11 a.m. near Lake Hughes Road,...

Continue Reading
Stifel Analyst Sets $82 Price Target for Solventum with Buy Rating

Updated Category News Views 74

Stifel Initiates Coverage on Solventum In a significant move, Stifel has initiated coverage on Solventum (NYSE: SOLV), a versatile MedTech company, granting it a Buy rating along with a price target set at $82. Following its recent emergence as an independent entity through a spin-off, Solventum boasts a market capitalization of around $8.2 billion. The company operates...

Continue Reading